Safety and Quality > Our Work > Healthcare-Associated Infection Prevention Program > Carbapenemase-Producing Enterobacteriacaea (CPE) Guide

Recommendations for the control of Carbapenemase-producing Enterobacteriaceae 

In 2017, the Commission worked in partnership with the Australasian Society of Infectious Diseases, Australasian College of Infection Prevention and Control, Public Health Laboratory Network and Australasian Society of Antimicrobials to update recommendations for the management and testing of patients with carbapenemase-producing Enterobacteriaceae (CPE). Subsequently, taxonomic studies have narrowed the definition of the family Enterobacteriaceae. Some previous members of this family are now included in other families within the order Enterobacterales, and this term is now used in many publications (ie carbapenemase-producing Enterobacterales).

The Commission’s CPE Guide is divided into 5 sections: Planning, preparation and prevention; CPE screening and surveillance; Strategies to reduce CPE transmission; Outbreak management; and Laboratory screening and confirmation methods. The Guide includes recommendations for patient management consistent with the 2010 version of the Australian Guidelines for the Prevention and Control of Infection in Healthcare.

Download the Recommendations for the control of Carbapenemase-producing Enterobacteriaceae (PDF 3MB)


The following supporting information and resources have also been developed:

Control of CPE: Information for patients (PDF 173KB) (Word 761KB)

Control of CPE: Checklist for ward staff and after hours managers (PDF 255KB) (Word 1MB)

Control of CPE: Information for clinicians and health service managers  (PDF 227KB) (Word 761KB)

Control of CPE: Information for clinicians  (PDF 178KB) (Word 340KB)